Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships
- PMID: 26670218
- PMCID: PMC4761836
- DOI: 10.1089/AID.2015.0296
Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships
Abstract
Background: Antiretroviral therapy (ART) markedly reduces the risk of HIV-1 transmission in serodiscordant partnerships. We previously found that younger age and higher CD4 counts were associated with delayed initiation of ART by HIV-1-infected partners in serodiscordant partnerships. Among those initiating ART, we sought to explore whether those same factors were associated with failure to achieve viral suppression.
Methods: In a prospective study of HIV-1-infected persons who had a known heterosexual HIV-1-uninfected partner in Kenya and Uganda [Partners Pre-Exposure Prophylaxis (PrEP) Study], we used Cox proportional hazards regression to evaluate correlates of viral nonsuppression (HIV-1 RNA >80 copies/ml).
Results: Of 1,035 HIV-1-infected participants initiating ART, 867 (84%) achieved viral suppression: 77% by 6 months and 86% by 12 months. Younger age [adjusted hazard ratio (aHR) 1.05 for every 5 years younger; p = .006], lower pretreatment CD4 count (aHR 1.26; p = .009 for ≤250 compared with >250 cells/μl), and higher pretreatment HIV-1 RNA quantity (aHR 1.21 per log10; p < .001) independently predicted failure to achieve viral suppression. Following initial viral suppression, 8.8% (76/867) experienced virologic rebound (HIV-1 RNA >200 copies/ml): 6.3% and 11.5% by 6 and 12 months after initial suppression, respectively. Age was the only factor associated with increased risk of virologic rebound (aHR 1.33 for every 5 years younger; p = .005).
Conclusions: For HIV-1-infected persons in serodiscordant couples, younger age was associated with delayed ART initiation, failure to achieve viral suppression, and increased risk of virologic rebound. Motivating ART initiation and early adherence is a key to achieving and sustaining viral suppression.
Figures
Similar articles
-
Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.PLoS Med. 2016 Aug 23;13(8):e1002099. doi: 10.1371/journal.pmed.1002099. eCollection 2016 Aug. PLoS Med. 2016. PMID: 27552090 Free PMC article.
-
Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda.AIDS Behav. 2017 Aug;21(8):2509-2518. doi: 10.1007/s10461-017-1829-z. AIDS Behav. 2017. PMID: 28634661 Free PMC article.
-
HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy.J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):579-84. doi: 10.1097/QAI.0000000000001019. J Acquir Immune Defic Syndr. 2016. PMID: 27070123 Free PMC article.
-
[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Enferm Infecc Microbiol Clin. 2012. PMID: 22633764 Spanish.
-
Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy.PLoS One. 2013;8(2):e55747. doi: 10.1371/journal.pone.0055747. Epub 2013 Feb 13. PLoS One. 2013. PMID: 23418455 Free PMC article. Review.
Cited by
-
Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment.South Afr J HIV Med. 2020 Aug 11;21(1):1107. doi: 10.4102/sajhivmed.v21i1.1107. eCollection 2020. South Afr J HIV Med. 2020. PMID: 32934834 Free PMC article.
-
Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.BMC Infect Dis. 2020 Oct 6;20(1):727. doi: 10.1186/s12879-020-05461-1. BMC Infect Dis. 2020. PMID: 33023498 Free PMC article.
-
Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana.J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):557-565. doi: 10.1097/QAI.0000000000001715. J Acquir Immune Defic Syndr. 2018. PMID: 29771781 Free PMC article.
-
First-Line Antiretroviral Regimen Failure and Determinants in an Urban HIV Clinic at Phramongkutklao Hospital, Bangkok, Thailand: 20 Years Experience.HIV AIDS (Auckl). 2021 Mar 4;13:261-269. doi: 10.2147/HIV.S295512. eCollection 2021. HIV AIDS (Auckl). 2021. PMID: 33692637 Free PMC article.
-
Salvage Antiretroviral Therapy: Time for "DeNUKElearization"?J Infect Dis. 2020 Apr 7;221(9):1390-1393. doi: 10.1093/infdis/jiz283. J Infect Dis. 2020. PMID: 31136663 Free PMC article. No abstract available.
References
-
- Joint United Nations Programme on HIV/AIDS. The Gap Report.UNAIDS, Geneva, 2014
-
- Quinn TC, Wawer MJ, Sewankambo N, et al. : Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921–929 - PubMed
-
- Thompson MA, Aberg JA, Cahn P, et al. : Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 2010;304:321–333 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous